Atypical presentation of serious pelvic inflammatory disease following mifepristone-induced medical abortion.
Mifepristone-induced abortion is increasingly common. Recent alerts have highlighted the occurrence of infrequent but serious complications. We report a case of serious bacterial infection after medical termination that occurred in the absence of the usual signs of infection.
Lawton
Beverley A
BA
Department of Primary Care and General Practice, Wellington School of Medicine and Health Sciences, PO Box 7343, Wellington South, New Zealand. bevlawton@wnmeds.ac.nz
Rose
Sally B
SB
Shepherd
Jill
J
D000028:Abortion, Induced / Q000009:adverse effects* / Q000379:methods; D000328:Adult; D000701:Analgesics, Opioid / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D005260:Female; D006069:Gonorrhea / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007958:Leukocyte Count; D015735:Mifepristone / Q000008:administration & dosage / Q000009:adverse effects*; D009344:Neisseria gonorrhoeae / Q000302:isolation & purification; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D011247:Pregnancy; D013290:Streptococcal Infections / Q000188:drug therapy; D013610:Tachycardia
D000701:Analgesics, Opioid; D000900:Anti-Bacterial Agents; D015735:Mifepristone